global view constructed of white lines

Blog

Chordoma Trial at PNI
February 27, 2020

New Chordoma Clinical Trial at Pacific Brain Tumor Center

by Guest Author

The Pacific Brain Tumor Center is recruiting patients with a rare cancer of the skull and spine for a groundbreaking clinical trial. The Brain Tumor Center is affiliated with Pacific Neuroscience Institute and Providence Saint John’s Health Center. January 14, 2020, Santa Monica, CA – The approved...

February 7, 2020

Pacific Brain Health Center: Seeking A Cure For Alzheimer’s Disease

by Zara Jethani

Pacific Neuroscience Institute brain health specialists are striving to find a cure for Alzheimer's disease, which is the most common type of dementia. In the United States, about 5.5 million people are affected by Alzheimer's disease, and the worldwide prevalence is estimated to be as high as 24 million. Watch this video to find out about research and clinical trials at the Pacific Brain Health Center at PNI.

clinical trial banner
January 27, 2020

Important Lewy Body Dementia Clinical Trial

by Guest Author

Pacific Neuroscience Institute offers final enrollment into important clinical trial for patients with Lewy body dementia. Find out more about this study and eligibility criteria.

Clinical Trials banner
January 18, 2020

Clinical Trials Round Up: January 2020

by Mini Gill

Pacific Neuroscience Institute has a strong roster of clinical trials for a number of neurological conditions including brain tumor, Cushing's disease and Lewy bodies dementia. Find out more.

Man and a woman holding hands outside
January 14, 2020

New Chordoma Clinical Trial at Pacific Brain Tumor Center

by Guest Author

The Pacific Brain Tumor Center is recruiting patients with chordoma, a rare cancer of the skull and spine for a groundbreaking clinical trial. The Brain Tumor Center is affiliated with Pacific Neuroscience Institute and Providence Saint John’s Health Center.

clinical trials banner
December 26, 2019

Clinical Trials Round Up: December 2019

by Mini Gill

Find out about Pacific Neuroscience Institute's leading edge clinical trials for Lewy Bodies dementia, Cushing's disease, Alzheimer's, brain tumor and more.

September 5, 2019

Pacific Brain Health Center: Dementia and Alzheimer’s Research

by Zara Jethani

At the Pacific Brain Health Center in Santa Monica, our experts treat a wide range of neurocognitive conditions that affect the brain such as dementia and Alzheimer's disease. As these are not curable at this time, clinical trials and research are necessary to develop new and more effective ways of halting and even reversing cognitive decline in these diseases. Find out more in this informative video.

La Odisea 2019
Dr. Kesari with two peers
Dr. Kesari at "The Duke" Awards 2019
special service award ceremony
Dr. Santosh Kesari holding an award
Dr. Santosh Kesari and Kirk Cameron
Dr. Santosh Kesari and Rick Muchow
"The Duke" Awards 2019
Dr. Santosh Kesari at "The Duke" awards
Dr. Santosh Kesari at an award ceremony
Dr. Santosh Kesari at an award ceremony
Doctors O'Day, Kelly and Kesari
Dr. Santosh Kesari at an awards ceremony
May 8, 2019

Professional Spotlight: Dr. Santosh Kesari Awarded “The Duke” at 34th Annual Odyssey Ball

by Guest Author

The John Wayne Cancer Institute Auxiliary (JWCIA) honored neurologist and neuro-oncologist Santosh Kesari, MD, PhD, with "The Duke" Special Service Award, and philanthropist and President of Premier Girls Fastpitch Dan Hay with the Generation of Hope Award, at La Odisea, the 34th Odyssey Ball on May 4, 2019. Read more.

Rich Muchow at Saddleback Church
May 1, 2019

Patient Story: Making an Impact in Glioblastoma Treatment

by Guest Author

The research arm at Pacific Neuroscience Institute confronts some of medicine’s biggest brain tumor challenges. Read this story about glioblastoma and the innovative clinical trial treatment a patient received.

Rendering of a DNA strand
April 8, 2019

Biopsy-Free Analysis of Brain Cancer

by Achal S. Achrol

A recently published paper by Pacific Neuroscience Institute researchers suggests a promising new approach for a biopsy-free method to identify primary brain tumor genetics for personalized treatment options.

Last updated: April 10th, 2019